JPMorgan Chase & Co’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-268,585
| Closed | -$18.2M | – | 5007 |
|
|
2019
Q3 | $18.2M | Buy |
268,585
+247,042
| +1,147% | +$16.8M | ﹤0.01% | 1421 |
|
|
2019
Q2 | $1.21M | Sell |
21,543
-101,288
| -82% | -$5.71M | ﹤0.01% | 2950 |
|
|
2019
Q1 | $8.61M | Buy |
122,831
+115,600
| +1,599% | +$8.1M | ﹤0.01% | 1813 |
|
|
2018
Q4 | $466K | Buy |
7,231
+1,086
| +18% | +$70K | ﹤0.01% | 3415 |
|
|
2018
Q3 | $432K | Buy |
6,145
+813
| +15% | +$57.2K | ﹤0.01% | 3550 |
|
|
2018
Q2 | $269K | Sell |
5,332
-83
| -2% | -$4.19K | ﹤0.01% | 3708 |
|
|
2018
Q1 | $170K | Sell |
5,415
-109
| -2% | -$3.42K | ﹤0.01% | 3771 |
|
|
2017
Q4 | $189K | Buy |
5,524
+4,475
| +427% | +$153K | ﹤0.01% | 3684 |
|
|
2017
Q3 | $33K | Buy |
1,049
+80
| +8% | +$2.52K | ﹤0.01% | 3887 |
|
|
2017
Q2 | $31K | Buy |
969
+67
| +7% | +$2.14K | ﹤0.01% | 3839 |
|
|
2017
Q1 | $29K | Buy |
902
+44
| +5% | +$1.42K | ﹤0.01% | 4051 |
|
|
2016
Q4 | $26K | Buy |
858
+358
| +72% | +$10.8K | ﹤0.01% | 4128 |
|
|
2016
Q3 | $14K | Sell |
500
-36,972
| -99% | -$1.04M | ﹤0.01% | 3809 |
|
|
2016
Q2 | $970K | Buy |
37,472
+8,843
| +31% | +$229K | ﹤0.01% | 2774 |
|
|
2016
Q1 | $709K | Sell |
28,629
-3,768
| -12% | -$93.3K | ﹤0.01% | 2805 |
|
|
2015
Q4 | $1.14M | Sell |
32,397
-1,269
| -4% | -$44.7K | ﹤0.01% | 2632 |
|
|
2015
Q3 | $712K | Sell |
33,666
-170,204
| -83% | -$3.6M | ﹤0.01% | 2819 |
|
|
2015
Q2 | $5.67M | Buy |
203,870
+31,279
| +18% | +$869K | ﹤0.01% | 2020 |
|
|
2015
Q1 | $5.27M | Buy |
172,591
+52,316
| +43% | +$1.6M | ﹤0.01% | 2080 |
|
|
2014
Q4 | $3.85M | Buy |
+120,275
| New | +$3.85M | ﹤0.01% | 2197 |
|
|
2013
Q4 | – | Sell |
-10,116
| Closed | -$309K | – | 3850 |
|
|
2013
Q3 | $309K | Sell |
10,116
-7,087
| -41% | -$216K | ﹤0.01% | 3516 |
|
|
2013
Q2 | $546K | Buy |
+17,203
| New | +$546K | ﹤0.01% | 3185 |
|